Yuan Hai, Silverman Richard B
Department of Chemistry, Northwestern University, Evanston, IL 60208-3113, USA.
Bioorg Med Chem. 2006 Mar 1;14(5):1331-8. doi: 10.1016/j.bmc.2005.09.067. Epub 2005 Nov 2.
A series of potential substrates of gamma-aminobutyric acid aminotransferase (GABA-AT) with lipophilic bioisosteres of the carboxylic acid group (2-7) were synthesized and tested. Most of the synthesized compounds showed substrate activities with GABA-AT; 1H-tetrazole-5-propanamine (6) was the best of those tested. The potential time-dependent inhibitor of GABA-AT, 1H-tetrazole-5-(alpha-vinyl-propanamine) (8), was designed based on the structures of 6 and the antiepilepsy drug vigabatrin (4-aminohex-5-enoic acid, 1). The synthesized compound 8 showed time-dependent inhibition of GABA-AT, but its potency is lower than that of vigabatrin. Methylation of the tetrazole group in 8 resulted in loss of time-dependent activity, suggesting that the tetrazole ring, the carboxylate bioisostere, exists in its deprotonated form in the enzyme active site.
合成并测试了一系列带有羧酸基团亲脂性生物电子等排体的γ-氨基丁酸转氨酶(GABA-AT)潜在底物(2-7)。大多数合成化合物表现出对GABA-AT的底物活性;1H-四唑-5-丙胺(6)是测试的化合物中表现最佳的。基于6和抗癫痫药物氨己烯酸(4-氨基己-5-烯酸,1)的结构设计了GABA-AT的潜在时间依赖性抑制剂1H-四唑-5-(α-乙烯基-丙胺)(8)。合成的化合物8表现出对GABA-AT的时间依赖性抑制作用,但其效力低于氨己烯酸。8中四唑基团的甲基化导致时间依赖性活性丧失,这表明作为羧酸盐生物电子等排体的四唑环在酶活性位点以去质子化形式存在。